Track the Creo Medical Group plc stock price and the full directors' dealings record of the company, a listed equity based in United Kingdom. Shares are listed on the UK market, under the oversight of RNS (LSE). Market capitalisation: €66.2m. The latest transaction was filed on 2 June 2025 (Purchase). Among the most active insiders: Richard Rees. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Creo Medical Group plc Strong Buy (bullish), based on 2 analysts. Average price target: £55.00.
Fundamental score
Ranked 16,082 of 29,064 companies
49.0
score / 100
Value
45
Quality
54
FCF yld-30%
Earn yld8.0%
EV/EBITDA·
ROE-77%
Gross mgn40%
Net mgn88%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.